Cosmos Health Inc. Files 8-K with Key Disclosures

Ticker: COSM · Form: 8-K · Filed: Oct 17, 2025 · CIK: 1474167

Sentiment: neutral

Topics: 8-K, disclosure, company-update

TL;DR

Cosmos Health filed an 8-K on 10/17/25 for events on 10/15/25 - includes Reg FD, other events, and financials.

AI Summary

Cosmos Health Inc. filed an 8-K on October 17, 2025, reporting events as of October 15, 2025. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company, formerly known as Cosmos Holdings Inc. and Prime Estates & Developments Inc., is incorporated in Nevada and based in Thessaloniki, Greece.

Why It Matters

This 8-K filing provides important updates and disclosures for Cosmos Health Inc., which could impact investor understanding of the company's current status and future direction.

Risk Assessment

Risk Level: low — The filing is a standard 8-K reporting routine events and disclosures, not indicating any immediate or significant operational or financial distress.

Key Players & Entities

FAQ

What specific events are being disclosed under Regulation FD?

The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in the provided text.

What are the 'Other Events' being reported by Cosmos Health Inc.?

The filing lists 'Other Events' as a category, but the specific nature of these events is not detailed in the provided text.

When was Cosmos Health Inc. formerly known as Cosmos Holdings Inc. and Prime Estates & Developments Inc.?

The company was formerly known as Cosmos Holdings Inc. after a name change on January 6, 2014, and prior to that, as Prime Estates & Developments Inc. after a name change on October 8, 2009.

What is the principal executive address of Cosmos Health Inc.?

The principal executive address is 5 Agiou Georgiou, Pilea, Thessaloniki, Greece, 55438.

What is the SIC code for Cosmos Health Inc.?

The Standard Industrial Classification (SIC) code for Cosmos Health Inc. is 5122, which corresponds to Wholesale - Drugs Proprietary & Druggists' Sundries.

Filing Stats: 649 words · 3 min read · ~2 pages · Grade level 10.7 · Accepted 2025-10-17 11:09:20

Key Financial Figures

Filing Documents

01 REGULATION FD DISCLOSURE

ITEM 7.01 REGULATION FD DISCLOSURE. On October 16, 2025, Cosmos Health Inc., a Nevada corporation (the "Company"), issued a press release announcing that it had regained compliance with Nasdaq Listing Rule 5550(a)(2). A copy of the press release is attached as Exhibit 99.1 to this Form 8-K. In accordance with General Instruction B.2 to Form 8-K, the information in this Item 7.01, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in that filing.

01 OTHER EVENTS

ITEM 8.01 OTHER EVENTS. As previously disclosed, on November 6, 2024, the Company received a letter from the Listing Qualifications Department (the "Staff") of The NASDAQ Stock Market, LLC ("Nasdaq") notifying the Company that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement"), as the minimum bid price for the Company's listed securities was less than $1 for the previous 30 consecutive business days. On October 15, 2025, the Company received a letter from Nasdaq notifying the Company that the Staff had determined that the closing bid price of the Company's common stock had been at $1.00 per share or greater for at least 18 consecutive business days, from September 22, 2025 to October 15, 2025, and, accordingly, that the Company had regained compliance with the Minimum Bid Price Requirement and the matter was now closed.

01 FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS (d) Exhibits Exhibit No. Description 99.1 Press Release issued by Cosmos Health Inc., dated October 16, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. COSMOS HEALTH INC. Date: October 17, 2025 By: /s/ Georgios Terzis Georgios Terzis Chief Financial Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing